Analysis of the actions of angiotensin on the central nervous system of conscious dogs
I. A. Reid, V. L. Brooks, C. D. Rudolph and L. C. Keil Angiotensin II (ANG II) acts on the brain to elevate blood pressure (BP), stimulate drinking, increase the secretion of vasopressin and corticotropin (ACTH), and inhibit the secretion of renin. The present studies were designed to evaluate the p...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 1982-07, Vol.243 (1), p.82-R91 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | I. A. Reid, V. L. Brooks, C. D. Rudolph and L. C. Keil
Angiotensin II (ANG II) acts on the brain to elevate blood pressure (BP),
stimulate drinking, increase the secretion of vasopressin and corticotropin
(ACTH), and inhibit the secretion of renin. The present studies were
designed to evaluate the possible physiological significance of these
effects. The experiments were performed in conscious dogs with small
catheters chronically implanted in both carotid and both vertebral
arteries. ANG II was infused into both carotid or both vertebral arteries
in doses of 0.1, 0.33, 1.0, and 2.5 ng.kg-1.min-1. Intravertebral ANG II
produced dose-related increases in BP that were generally accompanied by
increases in heart rate. Intracarotid angiotensin also increased BP but did
not change heart rate. Intracarotid ANG II stimulated drinking and, at the
highest dose only, increased the secretion of vasopressin, ACTH, and
corticosteroids. Intravertebral and intracarotid ANG II suppressed plasma
renin activity (PRA). In a parallel series of experiments, the effects of
intravenous ANG II, in doses of 2, 5, 10, and 20 ng.kg-1.min-1, were
studied. These infusions produced dose-related increases in BP and water
intake and suppressed PRA. Only the highest dose of ANG II increased
vasopressin or corticosteroid secretion. Analysis of these results in terms
of calculated or measured changes in plasma ANG II concentration indicate
that the central cardiovascular and dipsogenic actions of angiotensin, as
well as the suppression of PRA, can be elicited by concentrations of the
peptide that are within the physiological range. On the other hand high,
probably supraphysiological, levels of ANG II are required to increase
vasopressin or ACTH secretion. |
---|---|
ISSN: | 0363-6119 0002-9513 1522-1490 |
DOI: | 10.1152/ajpregu.1982.243.1.R82 |